Proteins > Gamma-secretase subunit APH-1A
Page last updated: 2024-08-07 17:22:22
Gamma-secretase subunit APH-1A
A gamma-secretase subunit APH-1A that is encoded in the genome of human. [PRO:DNx, UniProtKB:Q96BI3]
Synonyms
APH-1a;
Aph-1alpha;
Presenilin-stabilization factor
Research
Bioassay Publications (31)
Timeframe | Studies on this Protein(%) | All Drugs % |
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 8 (25.81) | 29.6817 |
2010's | 20 (64.52) | 24.3611 |
2020's | 3 (9.68) | 2.80 |
Compounds (21)
Drugs with Inhibition Measurements
Drugs with Activation Measurements
Drug | Taxonomy | Measurement | Average (mM) | Bioassay(s) | Publication(s) |
cholanic acid | Homo sapiens (human) | EC50 | 5.7000 | 1 | 1 |
t0901317 | Homo sapiens (human) | EC50 | 3.6000 | 1 | 1 |
ly 450139 | Homo sapiens (human) | EC50 | 0.0769 | 2 | 2 |
ly 411575 | Homo sapiens (human) | EC50 | 0.0001 | 1 | 1 |
begacestat | Homo sapiens (human) | EC50 | 0.0141 | 3 | 3 |
e 2012 | Homo sapiens (human) | EC50 | 0.0830 | 1 | 1 |
mrk 560 | Homo sapiens (human) | EC50 | 0.0006 | 1 | 1 |
ro 4929097 | Homo sapiens (human) | EC50 | 0.0095 | 2 | 2 |
Drugs with Other Measurements
Notch Antagonists: Potential Modulators of Cancer and Inflammatory Diseases.Journal of medicinal chemistry, , 09-08, Volume: 59, Issue:17, 2016
SAR-studies of γ-secretase modulators with PPARγ-agonistic and 5-lipoxygenase-inhibitory activity for Alzheimer's disease.Bioorganic & medicinal chemistry letters, , Feb-15, Volume: 25, Issue:4, 2015
Notch Antagonists: Potential Modulators of Cancer and Inflammatory Diseases.Journal of medicinal chemistry, , 09-08, Volume: 59, Issue:17, 2016
Signal peptide peptidase and gamma-secretase share equivalent inhibitor binding pharmacology.The Journal of biological chemistry, , Dec-21, Volume: 282, Issue:51, 2007
Novel Notch-sparing gamma-secretase inhibitors derived from a peroxisome proliferator-activated receptor agonist library.Bioorganic & medicinal chemistry letters, , Sep-01, Volume: 20, Issue:17, 2010
Signal peptide peptidase and gamma-secretase share equivalent inhibitor binding pharmacology.The Journal of biological chemistry, , Dec-21, Volume: 282, Issue:51, 2007
Notch Antagonists: Potential Modulators of Cancer and Inflammatory Diseases.Journal of medicinal chemistry, , 09-08, Volume: 59, Issue:17, 2016
Development of clickable active site-directed photoaffinity probes for γ-secretase.Bioorganic & medicinal chemistry letters, , Apr-15, Volume: 22, Issue:8, 2012
Recent advances in the identification of gamma-secretase inhibitors to clinically test the Abeta oligomer hypothesis of Alzheimer's disease.Journal of medicinal chemistry, , Oct-22, Volume: 52, Issue:20, 2009
Signal peptide peptidase and gamma-secretase share equivalent inhibitor binding pharmacology.The Journal of biological chemistry, , Dec-21, Volume: 282, Issue:51, 2007
Small molecules targeting γ-secretase and their potential biological applications.European journal of medicinal chemistry, , Mar-15, Volume: 232, 2022
Notch Antagonists: Potential Modulators of Cancer and Inflammatory Diseases.Journal of medicinal chemistry, , 09-08, Volume: 59, Issue:17, 2016
Discovery of (R)-4-cyclopropyl-7,8-difluoro-5-(4-(trifluoromethyl)phenylsulfonyl)-4,5-dihydro-1H-pyrazolo[4,3-c]quinoline (ELND006) and (R)-4-cyclopropyl-8-fluoro-5-(6-(trifluoromethyl)pyridin-3-ylsulfonyl)-4,5-dihydro-2H-pyrazolo[4,3-c]quinoline (ELND007Journal of medicinal chemistry, , Jul-11, Volume: 56, Issue:13, 2013
Piperidine-derived gamma-secretase modulators.Bioorganic & medicinal chemistry letters, , Feb-01, Volume: 20, Issue:3, 2010
Recent advances in the identification of gamma-secretase inhibitors to clinically test the Abeta oligomer hypothesis of Alzheimer's disease.Journal of medicinal chemistry, , Oct-22, Volume: 52, Issue:20, 2009
Discovery of a novel series of Notch-sparing gamma-secretase inhibitors.Bioorganic & medicinal chemistry letters, , Jul-15, Volume: 18, Issue:14, 2008
Amide Bond Bioisosteres: Strategies, Synthesis, and Successes.Journal of medicinal chemistry, , 11-12, Volume: 63, Issue:21, 2020
Notch Antagonists: Potential Modulators of Cancer and Inflammatory Diseases.Journal of medicinal chemistry, , 09-08, Volume: 59, Issue:17, 2016
Discovery of 2-methylpyridine-based biaryl amides as γ-secretase modulators for the treatment of Alzheimer's disease.Bioorganic & medicinal chemistry letters, , Dec-01, Volume: 23, Issue:23, 2013
Recent advances in the identification of gamma-secretase inhibitors to clinically test the Abeta oligomer hypothesis of Alzheimer's disease.Journal of medicinal chemistry, , Oct-22, Volume: 52, Issue:20, 2009
Insensitivity to Abeta42-lowering nonsteroidal anti-inflammatory drugs and gamma-secretase inhibitors is common among aggressive presenilin-1 mutations.The Journal of biological chemistry, , Aug-24, Volume: 282, Issue:34, 2007
Notch Antagonists: Potential Modulators of Cancer and Inflammatory Diseases.Journal of medicinal chemistry, , 09-08, Volume: 59, Issue:17, 2016
Recent advances in the identification of gamma-secretase inhibitors to clinically test the Abeta oligomer hypothesis of Alzheimer's disease.Journal of medicinal chemistry, , Oct-22, Volume: 52, Issue:20, 2009
N-Substituted carbazolyloxyacetic acids modulate Alzheimer associated gamma-secretase.Bioorganic & medicinal chemistry letters, , Jan-01, Volume: 17, Issue:1, 2007
Signal peptide peptidase and gamma-secretase share equivalent inhibitor binding pharmacology.The Journal of biological chemistry, , Dec-21, Volume: 282, Issue:51, 2007
Small molecules targeting γ-secretase and their potential biological applications.European journal of medicinal chemistry, , Mar-15, Volume: 232, 2022
Notch Antagonists: Potential Modulators of Cancer and Inflammatory Diseases.Journal of medicinal chemistry, , 09-08, Volume: 59, Issue:17, 2016
Discovery of (R)-4-cyclopropyl-7,8-difluoro-5-(4-(trifluoromethyl)phenylsulfonyl)-4,5-dihydro-1H-pyrazolo[4,3-c]quinoline (ELND006) and (R)-4-cyclopropyl-8-fluoro-5-(6-(trifluoromethyl)pyridin-3-ylsulfonyl)-4,5-dihydro-2H-pyrazolo[4,3-c]quinoline (ELND007Journal of medicinal chemistry, , Jul-11, Volume: 56, Issue:13, 2013
Discovery of a novel [3.2.1] benzo fused bicyclic sulfonamide-pyrazoles as potent, selective and efficacious γ-secretase inhibitors.Bioorganic & medicinal chemistry letters, , Feb-15, Volume: 23, Issue:4, 2013
Effect of helical conformation and side chain structure on γ-secretase inhibition by β-peptide foldamers: insight into substrate recognition.Journal of medicinal chemistry, , Feb-28, Volume: 56, Issue:4, 2013
Recent advances in the identification of gamma-secretase inhibitors to clinically test the Abeta oligomer hypothesis of Alzheimer's disease.Journal of medicinal chemistry, , Oct-22, Volume: 52, Issue:20, 2009
Discovery of begacestat, a Notch-1-sparing gamma-secretase inhibitor for the treatment of Alzheimer's disease.Journal of medicinal chemistry, , Dec-11, Volume: 51, Issue:23, 2008
Generation of Leads for γ-Secretase Modulation.Journal of medicinal chemistry, , 08-13, Volume: 63, Issue:15, 2020
Secretase inhibitors for the treatment of Alzheimer's disease: Long road ahead.European journal of medicinal chemistry, , Mar-25, Volume: 148, 2018
Discovery of a Tetrahydrobenzisoxazole Series of γ-Secretase Modulators.ACS medicinal chemistry letters, , Oct-12, Volume: 8, Issue:10, 2017
Gamma Secretase Modulators: New Alzheimer's Drugs on the Horizon?Journal of medicinal chemistry, , Aug-25, Volume: 59, Issue:16, 2016
Potent benzoazepinone γ-secretase modulators with improved bioavailability.Bioorganic & medicinal chemistry letters, , Sep-01, Volume: 25, Issue:17, 2015
Discovery of 2-methylpyridine-based biaryl amides as γ-secretase modulators for the treatment of Alzheimer's disease.Bioorganic & medicinal chemistry letters, , Dec-01, Volume: 23, Issue:23, 2013
Design and synthesis of a novel series of bicyclic heterocycles as potent γ-secretase modulators.Journal of medicinal chemistry, , Nov-08, Volume: 55, Issue:21, 2012
Cyclic hydroxyamidines as amide isosteres: discovery of oxadiazolines and oxadiazines as potent and highly efficacious γ-secretase modulators in vivo.Journal of medicinal chemistry, , Jan-12, Volume: 55, Issue:1, 2012
Discovery of fused 5,6-bicyclic heterocycles as γ-secretase modulators.Bioorganic & medicinal chemistry letters, , Jan-15, Volume: 21, Issue:2, 2011
Iminoheterocycles as gamma-secretase modulators.Bioorganic & medicinal chemistry letters, , Sep-15, Volume: 20, Issue:18, 2010
Notch Antagonists: Potential Modulators of Cancer and Inflammatory Diseases.Journal of medicinal chemistry, , 09-08, Volume: 59, Issue:17, 2016
Discovery of a Novel, Potent Spirocyclic Series of γ-Secretase Inhibitors.Journal of medicinal chemistry, , Nov-25, Volume: 58, Issue:22, 2015
4-substituted cyclohexyl sulfones as potent, orally active gamma-secretase inhibitors.Bioorganic & medicinal chemistry letters, , Jan-15, Volume: 16, Issue:2, 2006
Secretase inhibitors for the treatment of Alzheimer's disease: Long road ahead.European journal of medicinal chemistry, , Mar-25, Volume: 148, 2018
Notch Antagonists: Potential Modulators of Cancer and Inflammatory Diseases.Journal of medicinal chemistry, , 09-08, Volume: 59, Issue:17, 2016
Design, synthesis, and in vivo characterization of a novel series of tetralin amino imidazoles as γ-secretase inhibitors: discovery of PF-3084014.Bioorganic & medicinal chemistry letters, , May-01, Volume: 21, Issue:9, 2011
Secretase inhibitors for the treatment of Alzheimer's disease: Long road ahead.European journal of medicinal chemistry, , Mar-25, Volume: 148, 2018
Discovery of (R)-4-cyclopropyl-7,8-difluoro-5-(4-(trifluoromethyl)phenylsulfonyl)-4,5-dihydro-1H-pyrazolo[4,3-c]quinoline (ELND006) and (R)-4-cyclopropyl-8-fluoro-5-(6-(trifluoromethyl)pyridin-3-ylsulfonyl)-4,5-dihydro-2H-pyrazolo[4,3-c]quinoline (ELND007Journal of medicinal chemistry, , Jul-11, Volume: 56, Issue:13, 2013
Discovery of a novel [3.2.1] benzo fused bicyclic sulfonamide-pyrazoles as potent, selective and efficacious γ-secretase inhibitors.Bioorganic & medicinal chemistry letters, , Feb-15, Volume: 23, Issue:4, 2013
Application of the bicyclo[1.1.1]pentane motif as a nonclassical phenyl ring bioisostere in the design of a potent and orally active γ-secretase inhibitor.Journal of medicinal chemistry, , Apr-12, Volume: 55, Issue:7, 2012
Recent advances in the identification of gamma-secretase inhibitors to clinically test the Abeta oligomer hypothesis of Alzheimer's disease.Journal of medicinal chemistry, , Oct-22, Volume: 52, Issue:20, 2009
Discovery of (R)-4-cyclopropyl-7,8-difluoro-5-(4-(trifluoromethyl)phenylsulfonyl)-4,5-dihydro-1H-pyrazolo[4,3-c]quinoline (ELND006) and (R)-4-cyclopropyl-8-fluoro-5-(6-(trifluoromethyl)pyridin-3-ylsulfonyl)-4,5-dihydro-2H-pyrazolo[4,3-c]quinoline (ELND007Journal of medicinal chemistry, , Jul-11, Volume: 56, Issue:13, 2013
Discovery of a novel [3.2.1] benzo fused bicyclic sulfonamide-pyrazoles as potent, selective and efficacious γ-secretase inhibitors.Bioorganic & medicinal chemistry letters, , Feb-15, Volume: 23, Issue:4, 2013
Enables
This protein enables 4 target(s):
Target | Category | Definition |
protein binding | molecular function | Binding to a protein. [GOC:go_curators] |
enzyme binding | molecular function | Binding to an enzyme, a protein with catalytic activity. [GOC:jl] |
protein-macromolecule adaptor activity | molecular function | The binding activity of a protein that brings together two or more macromolecules in contact, permitting those molecules to function in a coordinated way. The adaptor can bring together two proteins, or a protein and another macromolecule such as a lipid or a nucleic acid. [GOC:bf, GOC:mah, GOC:vw] |
endopeptidase activator activity | molecular function | Binds to and increases the activity of an endopeptidase. [GOC:dph, GOC:tb] |
Located In
This protein is located in 11 target(s):
Target | Category | Definition |
Golgi membrane | cellular component | The lipid bilayer surrounding any of the compartments of the Golgi apparatus. [GOC:mah] |
early endosome | cellular component | A membrane-bounded organelle that receives incoming material from primary endocytic vesicles that have been generated by clathrin-dependent and clathrin-independent endocytosis; vesicles fuse with the early endosome to deliver cargo for sorting into recycling or degradation pathways. [GOC:mah, NIF_Subcellular:nlx_subcell_20090701, PMID:19696797] |
endoplasmic reticulum | cellular component | The irregular network of unit membranes, visible only by electron microscopy, that occurs in the cytoplasm of many eukaryotic cells. The membranes form a complex meshwork of tubular channels, which are often expanded into slitlike cavities called cisternae. The ER takes two forms, rough (or granular), with ribosomes adhering to the outer surface, and smooth (with no ribosomes attached). [ISBN:0198506732] |
endoplasmic reticulum membrane | cellular component | The lipid bilayer surrounding the endoplasmic reticulum. [GOC:mah] |
Golgi apparatus | cellular component | A membrane-bound cytoplasmic organelle of the endomembrane system that further processes the core oligosaccharides (e.g. N-glycans) added to proteins in the endoplasmic reticulum and packages them into membrane-bound vesicles. The Golgi apparatus operates at the intersection of the secretory, lysosomal, and endocytic pathways. [ISBN:0198506732] |
plasma membrane | cellular component | The membrane surrounding a cell that separates the cell from its external environment. It consists of a phospholipid bilayer and associated proteins. [ISBN:0716731363] |
synaptic vesicle | cellular component | A secretory organelle, typically 50 nm in diameter, of presynaptic nerve terminals; accumulates in high concentrations of neurotransmitters and secretes these into the synaptic cleft by fusion with the 'active zone' of the presynaptic plasma membrane. [PMID:10099709, PMID:12563290] |
endosome membrane | cellular component | The lipid bilayer surrounding an endosome. [GOC:mah] |
membrane | cellular component | A lipid bilayer along with all the proteins and protein complexes embedded in it and attached to it. [GOC:dos, GOC:mah, ISBN:0815316194] |
Golgi cisterna membrane | cellular component | The lipid bilayer surrounding any of the thin, flattened compartments that form the central portion of the Golgi complex. [GOC:ecd, GOC:mah] |
presynaptic membrane | cellular component | A specialized area of membrane of the axon terminal that faces the plasma membrane of the neuron or muscle fiber with which the axon terminal establishes a synaptic junction; many synaptic junctions exhibit structural presynaptic characteristics, such as conical, electron-dense internal protrusions, that distinguish it from the remainder of the axon plasma membrane. [GOC:jl, ISBN:0815316194] |
Active In
This protein is active in 1 target(s):
Target | Category | Definition |
endoplasmic reticulum | cellular component | The irregular network of unit membranes, visible only by electron microscopy, that occurs in the cytoplasm of many eukaryotic cells. The membranes form a complex meshwork of tubular channels, which are often expanded into slitlike cavities called cisternae. The ER takes two forms, rough (or granular), with ribosomes adhering to the outer surface, and smooth (with no ribosomes attached). [ISBN:0198506732] |
Part Of
This protein is part of 1 target(s):
Target | Category | Definition |
gamma-secretase complex | cellular component | A protein complex that has aspartic-type endopeptidase activity and contains a presenilin catalytic subunit (either PSEN1 or PSEN2), an APH1 subunit (multiple genes and splice variants exist), nicastrin (NCT), and presenilin enhancer (aka PEN-2 or Psenen), as the core complex. Variants of the complex with different subunit compositions differ in localization and specific substrates. Additionally, variants of the complex exist that contain a additional regulatory subunit as well as the four core subunits; known regulatory subunits include gamma-secretase-activating protein (aka gSAP), TMP1 (aka TMED10), and CD147 antigen (aka basigin). Gamma-secretase cleaves type I transmembrane protein substrates, including the cell surface receptor Notch and the amyloid-beta precursor protein. [GOC:krc, PMID:15286082, PMID:15890777, PMID:17047368, PMID:22122073, PMID:25565961, PMID:28320827, PMID:32616437] |
Involved In
This protein is involved in 10 target(s):
Target | Category | Definition |
metanephros development | biological process | The process whose specific outcome is the progression of the metanephros over time, from its formation to the mature structure. In mammals, the metanephros is the excretory organ of the fetus, which develops into the mature kidney and is formed from the rear portion of the nephrogenic cord. The metanephros is an endocrine and metabolic organ that filters the blood and excretes the end products of body metabolism in the form of urine. [GOC:bf, ISBN:0192800752] |
membrane protein ectodomain proteolysis | biological process | The proteolytic cleavage of transmembrane proteins and release of their ectodomain (extracellular domain). [GOC:jl, http://www.copewithcytokines.de/] |
Notch receptor processing | biological process | The series of successive proteolytic cleavages of the Notch protein, which result in an active form of the receptor. [PMID:12651094, PMID:14986688] |
positive regulation of endopeptidase activity | biological process | Any process that increases the frequency, rate or extent of endopeptidase activity, the endohydrolysis of peptide bonds within proteins. [GOC:dph, GOC:tb] |
protein processing | biological process | Any protein maturation process achieved by the cleavage of a peptide bond or bonds within a protein. Protein maturation is the process leading to the attainment of the full functional capacity of a protein. [GOC:curators, GOC:jl, GOC:jsg] |
membrane protein intracellular domain proteolysis | biological process | The proteolytic cleavage of a transmembrane protein leading to the release of an intracellular domain. [PMID:12808018] |
amyloid-beta formation | biological process | The generation of amyloid-beta by cleavage of the amyloid precursor protein (APP). [GOC:mah] |
amyloid precursor protein metabolic process | biological process | The chemical reactions and pathways involving amyloid precursor protein (APP), the precursor of amyloid-beta, a glycoprotein associated with Alzheimer's disease. [GOC:go_curators] |
amyloid precursor protein catabolic process | biological process | The chemical reactions and pathways resulting in the breakdown of amyloid precursor protein (APP), the precursor of amyloid-beta, a glycoprotein associated with Alzheimer's disease. [GOC:go_curators] |
Notch signaling pathway | biological process | The series of molecular signals initiated by an extracellular ligand binding to the receptor Notch on the surface of a target cell, and ending with the regulation of a downstream cellular process, e.g. transcription. [GOC:go_curators, GOC:signaling] |